PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.

PHASQ
PhaseBio Pharmaceuticals, Inc.US flagOther OTC
0.00
USD
+0.00
- -

Income Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
Sales/Revenue/Turnover
- -
- -
1
2
- -
11
+ Sales & Services Revenue
- -
- -
1
2
- -
11
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-1
-2
- -
-11
- Operating Expenses
10
9
20
42
85
118
+ Selling, General & Admin
2
2
5
11
13
16
+ Research & Development
7
6
15
31
72
102
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-10
-9
-20
-40
-85
-107
- Non-Operating (Income) Loss
- -
2
4
- -
14
22
+ Interest Expense, Net
- -
3
4
-1
1
1
+ Interest Expense
- -
3
4
1
1
1
- Interest Income
- -
- -
- -
2
- -
- -
+ Other Non-Op (Income) Loss
- -
-1
1
- -
13
21
Pretax Income
-9
-10
-24
-39
-99
-129
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
2
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-9
-10
-24
-39
-99
-131
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-9
-10
-24
-39
-99
-131
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-9
-10
-24
-39
-99
-131
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-10
-24
-39
-99
-131
EBIT
-10
-9
-20
-40
-85
-107
EBITDA
-9
-8
-20
-40
-84
-106
EBITDA Margin (%)
- -
- -
-2,925
-1,675.65
- -
-974.69
EBITA
-10
-9
-20
-40
-85
-107
Gross Margin (%)
- -
- -
100
100
- -
100
Operating Margin (%)
- -
- -
-2,940.72
-1,683.02
- -
-991.25
Profit Margin (%)
- -
- -
-3,569.76
-1,662.3
- -
-1,210.15
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
1
2
Basic Weighted Avg Shares
12
1
5
27
29
44
Basic EPS, GAAP
-0.74
-13.78
-4.49
-1.43
-3.39
-2.98
Basic EPS from Cont Ops
-0.74
-13.78
-4.49
-1.43
-3.39
-2.98
Diluted Weighted Avg Shares
12
1
5
27
29
44
Diluted EPS, GAAP
-0.74
-13.78
-4.49
-1.43
-3.39
-2.98
Diluted EPS from Cont Ops
-0.74
-13.78
-4.49
-1.43
-3.39
-2.98

Balance Sheet (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
Total Current Assets
4
14
63
79
40
49
+ Cash, Cash Equivalents & STI
4
13
61
74
28
42
+ Cash & Cash Equivalents
4
13
61
74
28
42
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
1
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
1
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
4
12
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
4
10
12
+ Property, Plant & Equip, Net
- -
- -
- -
4
10
12
+ Property, Plant & Equip
2
2
2
6
12
16
- Accumulated Depreciation
2
2
2
2
2
4
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
Total Assets
4
14
63
82
50
61
+ Payables & Accruals
1
1
4
4
7
18
+ Accounts Payable
- -
- -
2
3
4
13
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
2
1
3
5
+ ST Debt
- -
13
- -
3
6
6
+ ST Borrowings
- -
13
- -
2
5
5
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
3
1
2
2
4
+ Deferred Revenue
- -
- -
- -
- -
- -
2
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
3
1
2
2
3
Total Current Liabilities
1
18
5
8
15
28
+ LT Debt
- -
3
8
14
8
2
+ LT Borrowings
- -
3
8
12
7
1
+ LT Finance Leases
- -
- -
- -
2
2
1
+ Other LT Liabilities
90
91
- -
- -
52
123
+ Accrued Liabilities
- -
- -
- -
- -
- -
8
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
90
91
- -
- -
52
116
Total Noncurrent Liabilities
90
94
8
14
61
126
Total Liabilities
91
112
12
23
76
154
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
2
2
174
222
236
299
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
2
2
174
222
236
299
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-89
-99
-123
-162
-261
-392
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-87
-97
51
60
-25
-93
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-87
-97
51
60
-25
-93
Total Liabilities & Equity
4
14
63
82
50
61
Shares Outstanding
20
20
24
29
29
48
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
2
2
2
Net Debt
-4
2
-54
-59
-16
-35
Net Debt to Equity
4.26
-2.13
-105.11
-98.9
63.46
37.65
Tangible Common Equity Ratio
-2,117.61
-690.94
80.8
72.71
-50.05
-153.67
Current Ratio
4.6
0.78
13.68
9.3
2.68
1.75
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
+ Net Income
-9
-10
-24
-39
-99
-131
+ Depreciation & Amortization
- -
- -
- -
- -
1
2
+ Non-Cash Items
- -
2
5
2
42
52
+ Stock-Based Compensation
- -
- -
- -
1
2
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
2
4
- -
40
50
+ Chg in Non-Cash Work Cap
- -
- -
2
-2
-4
29
+ (Inc) Dec in Accts Receiv
- -
- -
- -
-1
1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-2
-8
8
+ Inc (Dec) in Accts Payable
-1
- -
3
- -
3
13
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
9
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
-8
-17
-40
-60
-47
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-1
-1
-3
+ Acq of Fixed Prod Assets
- -
- -
- -
-1
-1
-3
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
43
46
3
60
+ Increase in Capital Stock
- -
- -
43
46
3
60
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
9
- -
- -
- -
- -
- -
+ Dec in LT Investment
11
- -
- -
- -
- -
- -
+ Inc in LT Investment
-2
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
9
- -
- -
-1
-1
-3
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
18
4
7
-3
-5
+ Cash From Debt
- -
18
4
8
- -
- -
+ Repayments of Debt
- -
- -
- -
-1
-3
-5
+ Other Financing Activities
- -
- -
18
- -
15
9
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
18
65
54
15
64
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
10
48
13
-46
14
EBITDA
-9
-8
-20
-40
-84
-106
EBITDA Margin (%)
- -
- -
-2,925
-1,675.65
- -
-974.69
Free Cash Flow
-10
-8
-17
-41
-61
-50
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
10
-13
-33
-64
-56
Free Cash Flow per Basic Share
-0.79
-11.4
-3.24
-1.48
-2.11
-1.14
Price/Free Cash Flow
- -
- -
-0.97
-4.35
-1.67
-2.56
Cash Flow to Net Income
1.05
0.81
0.72
1.01
0.61
0.36
Capital Expenditures
- -
- -
- -
-1
-1
-3